Experiences with

Dutasteride

First a recap of the REDUCE trial: "The Reduction by Dutasteride of Prostate Cancer Events clinical trial is an international, multicenter, double-blind, placebo controlled chemoprevention study designed to determine if dutasteride 0.5 mg daily decreases the risk of biopsy detectable prostate cancer.

The two PCa prevention studies (Finasteride [Proscar] & Dutasteride [Avodart]) both reported a big reduction in lesser PCa, but an unexpected higher proportion of Gleason score 8-10. The new (large) study looked at 5-ARI use men with BPH.

I have been taking Avodart (now Dutasteride) for years, he said to stop taking it as it does no good. Is that an accurate assessment? Ed Roge

the bicalutamide/dutasteride group."